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Clinical Relevance
The airway inflammatory milieu at or before birth may have important effects on the development of antiviral innate immunity at the level of the epithelium. As rapid maturation of adaptive immunity from a tolerant (T helper cell type 2 [Th2]) to an anti-infective (Th1) state occurs in the neonatal period, the presence of a Th1 milieu appears to be key for the development of effective antiviral responses.
The pulmonary innate immune system matures rapidly in early life (1) , but the age of the first viral infection and hence the state of maturity of the immune system at the time are critical factors that predispose to both severe infection and the risk of long-term airways disease (2-4).
Respiratory syncytial virus (RSV) is the most common cause of severe respiratory infection in newborn babies and each year leads to more than 3 million hospitalizations and approximately 66,000 deaths worldwide each year (4) . Some infants have an inherent predisposition to severe RSV infection and a tendency to develop postinfectious wheezing, which is associated with increased proinflammatory cytokine production (5) . Previous studies have investigated the role of cytokines in the development of asthma early in life, particularly the T-helper cell type 2 (Th2) cytokine, IL-13. However, there are conflicting reports regarding the role of IL-13 in asthma development. It was shown that IL-13 can drive normal human pediatric primary bronchial epithelial cells (PBECs) toward an asthmatic phenotype in vitro (6) . In contrast, Williams and colleagues (7) described deficient IL-13 production in babies who later developed atopic disease. Furthermore, early-life bacterial and viral infections were shown to increase IL-13 responses (3). Gern and colleagues (8) examined peripheral blood responses to activation by phytohemagglutinin (PHA) in children and found that infants who wheezed with RSV infection had reduced PHA-induced IL-13 at birth, and babies with detectable PHAinduced IFN-g were less likely to wheeze in the first year.
Studies in murine models showed that production of IFN-g during RSV infection determined the outcome of subsequent RSV reinfections, and that mice infected for the first time as neonates had lower IFN-g responses than mice infected as adults (9) . Upon reinfection, IFN-g-deficient mice developed an enhanced lung response (2, 10) .
Work from Copenhaver and colleagues (11) showed that cord blood IFN-g responses were inversely related to the frequency of subsequent viral respiratory infections. Juntti and colleagues (5) measured cytokine responses to LPS stimulation in cord blood and found that IFN-g responses were lower in children hospitalized for RSV infection. Juntti and colleagues made the key observation that infants with a severe RSV infection have a different innate immunity cytokine profile before infection compared with healthy children. Taken together, these data suggest that early-life lung exposure to IFNs may influence antiviral immunity in the longer term more than exposure to IL-13.
Recently, the Copenhagen Prospective Studies of Asthma in Childhood 2000 study linked asthma development with the number of viral respiratory tract infections in the first year of life, but not with a particular viral trigger (12) . Airway epithelial cells are not only a physical barrier between the human body and the external environment (13) but also a key site in the innate immune response, being the first line of defense against lung pathogens. Activated epithelial cells are able to produce antiviral and proinflammatory cytokines that enhance the innate immune response and activate adaptive immunity; in the lung, a key function of IFN-g is to upregulate antiviral gene transcription (14) (15) (16) .
Environmental exposures in early life are also crucial in influencing how immune responses are programmed pre-and postnatally (17) . A study examining the role of the environment in the development of asthma and allergy was recently designed, comparing Amish and Hutterite children (18) . The Amish community follows traditional farming practices, whereas Hutterites live on large, highly industrialized, communal farms.
The study revealed that despite similar genetic ancestries and lifestyles there was 4 and 6 times lower incidence of asthma and allergic sensitization in Amish children. Endotoxin levels in Amish house dust were 6.8 times higher than in Hutterite house dust suggesting that the high endotoxin Amish environment has a protective effect against asthma via modulating innate immune responses (18) . von Mutius and Vercelli (19) described this IFN-g centered model and cited "farm living" as an example of an environment in which mothers live during pregnancy that is characterized by intense microbial exposure and is protective against asthma and allergies for their children later in life. These combined exposures, which occur at a crucial time for programming immune responses, upregulate regulatory T cell function and IFN-g production at birth, which in turn enhances innate immune responses (through increased expression of patternrecognition receptors) and dampens Th2 cell-dependent allergic inflammation in early childhood (19) . The ability to produce high levels of IFN-g at birth may ensure effective responses to respiratory viral infections in early life, thereby counteracting the contribution of these infections to increased asthma susceptibility (19) . The IFN-g priming in our cellular model mimics the increased IFN-g upregulation that occurs after microbial exposure, and helped us to identify the effects of IFN-g priming in the antiviral response early in life.
We investigated how IFN-g is able to modulate the innate immune response to RSV by the airway epithelium. We used an unbiased approach to identify the modulation in gene transcription induced by IFN-g-primed epithelium, and further investigated the mechanisms by which IFN-g priming may modulate the epithelial response to viral infection. In addition to transcription factors, gene expression can also be modulated in the longer term via epigenetic mechanisms. Post-transcriptional modifications of nucleosomal histones in the chromatin, including methylation, lead to changes in gene transcription that affect the cellular phenotype and reflect the nature and timing of the environmental stimulus (20) . We therefore investigated the potential epigenetic mechanisms employed by IFN-g to regulate antiviral gene transcription.
Some of the results of these studies have been previously reported in the form of abstracts (21, 22) .
Materials and Methods
Cell Culture and RSV Infection AALEB human bronchial epithelial cells (23) were cultured in bronchial epithelial cell growth medium (bronchial epithelial basal medium plus SingleQuots growth supplements; Lonza, Slough, UK), used at a passage number between 20 and 30, and plated in 24-well plates at z2 3 10 4 cells per well. PBECs were isolated from bronchial brushes from healthy controls undergoing a bronchoscopy. The subjects gave written informed consent and the study was approved by the South CentralSouthampton B National Research Ethics Service Committee (12/SC/0304). The PBECs were kept in culture in flasks coated with collagen (PureCol, Nutacon, The Netherlands) using bronchial epithelial growth medium. Cells at passage 2 or 3 were then plated in collagen-coated, 24-well plates at 1 3 10 4 cells per well for subsequent experiments.
PBECs and AALEB cells were prepared in 24-well plates and maintained for 48 hours in starvation media (bronchial epithelial basal medium supplemented with 13 ITS (insulin, transferrin, selenium; Life Biotechnology/Thermo Fisher Scientific, Waltham, MA) and 0.02% BSA (Sigma, Dorset, UK). When required, 24 hours before viral infection, IL-13 or IFN-g (both 10 ng/ml; R&D Systems, Abingdon, UK) was added to the media.
Before RSV infection, cells were washed twice with Dulbecco's modified Eagle's medium (Sigma) supplemented with 2 mM glutamine (Sigma) before RSV subtype A Memphis 37 (Amsbio, Abingdon, UK) (24) at a multiplicity of infection (MOI) of 1 was added to the appropriate wells in 200 ml for 2 hours at 37 8 C with gentle agitation. The cells were then washed twice with Dulbecco's modified Eagle's medium plus 2 mM glutamine and cultured for 48 hours in starvation media. Cells were harvested and stored in TriFast (peqGOLD; Peqlab, Southampton, UK) at 280 8 C before RNA was extracted.
RNA Extraction
RNA extraction was performed according to the manufacturer's instructions (Peqlabsee the data supplement).
Microarray Analysis
Global gene expression was assessed using Affymetrix GeneChip U133 Plus 2.0 (see the data supplement).
The microarray data has been uploaded to the GEO database (GEO accession number: GSE77154) (reviewer access link: https://www.ncbi.nlm.nih. gov/geo/query/acc.cgi?token = utmbyqyqbnmrxixandacc=GSE77154).
Epigenetic Inhibitors
AALEB cells were plated in 24-well plates at z2 3 10 4 cells per well, cultured for 48 hours, and then exposed to a range of epigenetic inhibitors for 6 hours in starvation media (Table E1 in the data supplement). IFN-g was then added at 10 ng/ml for 24 hours and cells were collected in TriFast (peqGOLD; Peqlab). RNA was extracted according to a standard protocol as described above.
qRT-PCR
For details regarding TaqMan gene expression assays, see the data supplement and Table E2 .
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed essentially as described previously (25) (see the data supplement). The antibodies and PCR primers used are listed in Tables E3 and E4 , respectively.
Production of Cell Lysates and Protein Quantitation
For details regarding Western blot experiments, see the data supplement.
Statistical Analysis
Data were analyzed with GraphPad Prism software, version 6, using one-way ANOVA (Holm-Sidak's multiple-comparisons test) for gene expression analysis and a two-tailed Wilcoxon paired t test for analysis of pulldown isolated chromatin from ChIP experiments. The number of samples varied between 3 and 9 as indicated in the figure legends. Error bars represent the mean with standard error of the mean (SEM).
Results

Viral Shedding Is Reduced in the Presence of IFN-g
To assess the effects of the local cytokine environment on the airway epithelium, we first investigated the effects of Th1 (IFN-g) and Th2 (IL-13) cytokines in modulating epithelial responses to viral infection. For these experiments, we used AALEB cells, a cell line derived from human airway epithelial cells (23) that was previously used by Contreras and colleagues (26) to study the link between p53 and IFN-g. AALEB cells were pretreated with IFN-g or IL-13 (27) and then infected with RSV ( Figure 1A ). RSV efficiently replicated within the AALEB cells as measured by qRT-PCR ( Figure 1B ). IFN-g pretreatment reduced RSV replication compared with unprimed cells, but IL-13 had no statistically significant effect on viral replication (P = 0.23; Figure 1C ).
IFN-g-Modulated Genes Are Involved in the Viral Innate Immune Response
We then performed unbiased gene expression analyses using microarrays to identify innate immune genes that may be responsible for the priming effect of IFN-g on the respiratory epithelium. Gene expression changes were determined for the following conditions compared with the untreated control: IFN-g treated, RSV infected, IFN-g pretreated, and RSV infected. (Figure 2A ). As expected, several genes involved in inflammation, the IFN response, and antigen presentation were upregulated after RSV infection in IFN-g-primed cells. As a consequence of IFN-g priming, among the top genes differentially expressed were the IFN-stimulated genes MX1, IFIT1, and IFIT3, which are known to inhibit viral replication. We focused on the antiviral receptor RIG-I (also known as DDX58) because of its key role in the detection and eradication of replicating viral genomes (28). RIG-I is known to be upregulated in Hela cells stimulated by IFN-g (29) and similarly in intestinal cells (30) . Furthermore, other groups have previously highlighted the robust link between RIG-I and viral load. Kato and colleagues demonstrated that RIG-I 2/2 mice are more susceptible to viral infections compared with control mice (31) . In addition, siRNAmediated knockout of RIG-I expression in human bronchial epithelial tissue showed reduced innate cytokine responses and rhinovirus replication (32) . Similarly, Foronjy and colleagues stated that silencing RIG-I in A549 epithelium had a significant impact on RSV infection (33) . Overall, the work already published clearly shows an association between RIG-I expression and modulation in viral infection. Furthermore, genetic association studies have already linked polymorphisms in this gene to viral respiratory illness (34) and asthma exacerbations (35) .
IFN-g upregulated the expression of RIG-I compared with both control cells and RSV-infected cells ( Figure 2B) . A further increase in RIG-I expression by IFN-g-primed RSV-infected cells was also observed and confirmed by qRT-PCR ( Figure 3 ). In addition to IFN-g effects on cells, we investigated the effects of IL-13. We observed no significant changes in RIG-I expression when the cells were primed with IL-13 with or without exposure to RSV.
We further investigated the relevance of this observation of increased RIG-I expression in response to IFN-g in PBECS. Similar to the case with AALEB cells, IFN-g priming caused upregulation of RIG-I expression in PBECS 24 hours after IFN-g treatment ( Figure 4A ). Intriguingly, in the PBECS this effect of IFN-g on RIG-I expression was still manifest up to 4 days after IFN-g was removed from the culture medium ( Figure 4B ). Furthermore, IFN-g reduced the viral load in IFN-g-primed, RSV-infected PBECs compared with RSV control cells and IL-13-primed, RSVinfected PBECs ( Figure 4C) . A further increase in RIG-I expression by IFN-g-primed, RSV-infected PBECs was also observed and confirmed by qRT-PCR ( Figure 4D ). Significance was not reached in PBECs due to the small number of repeats (n = 3) when viral load and RIG-I were measured after priming and RSV infection, but the data indicate a long-term effect of IFN-g priming on PBECS and suggest that epigenetic regulation of RIG-I expression may play a role alongside any temporary transcriptional regulation. Given their almost unlimited availability and the similarity of RIG-I responses in PBECs after IFN-g priming, we opted to continue analyzing the epigenetic control of gene regulation in AALEB cells. Epigenetic analysis requires great amounts of chromatin and an immortalized cell line like AALEB would be an ideal model to use for this project.
Effects of IFN-g Priming on Epigenetic Regulation of RIG-I Expression
We investigated whether the increase of RIG-I transcription induced by IFN-g priming correlated with epigenetic changes at the RIG-I promoter, and hence focused on changes in the levels of histone methylation associated with increased RIG-I transcription. In association with an increase in RIG-I mRNA detected 24 hours after IFN-g priming, we saw a significant reduction in methylation of the lysine 9 residue on histone 3 (H3K9me3) (Figure 5 ), but not of lysine 4 (H3K4) or lysine 27 (H3K27) at the RIG-I promoter ( Figure 5B ), in AALEB cells using ChIP. Trimethylation of H3K9 is associated with transcriptional repression, and hence its reduction after IFN-g priming is consistent with the observed increase in RIG-I expression. In addition, we investigated histone acetylation of the lysine 9 residue (H3K9ac) because this also has a functional link to gene expression (36) . In our cellular model, H3K9ac was not altered by IFN-g, indicating that H3K9ac may not be involved in IFN-g-regulated RIG-I expression. In addition, RNA polymerase II (RNApolII), an essential element in the transcription complex, was recruited to the RIG-I promoter as expected, but it did not change significantly with priming ( Figure 5C ).
Functional Effects of Epigenetic Markers on RIG-I Expression
To further analyze the epigenetic factors influenced by IFN-g priming and investigate their functional consequences, we employed small-molecule inhibitors of histone demethylases and methyltransferases (Table E1) to identify the role of histone methylation in RIG-I transcription ( Figure 6 ). First, we employed the methyltransferase inhibitors WDR5-103 and DZNep. WDR5-103 inhibits methylation of lysine 4 on histone H3 (H3K4me3) (37), whereas DZNep inhibits trimethylation of lysine 27 on histone H3 (H3K27me3) (38) . When cells were pretreated with either WDR5-0103 or DZNep with or without IFN-g priming, there was no effect on RIG-I transcription compared with the untreated cells (data not shown), further confirming that H3K4me3 and H3K27me3 were not involved in RIG-I modulation by IFN-g. Figure 3 . Detection of RIG-I mRNA in AALEB cells measured by qRT-PCR after cytokine priming and RSV infection. AALEB cells were left untreated (UNT) or primed with 10 ng/ml IL-13 (IL-13) or 10 ng/ml IFN-g (IFN-g) for 24 hours. AALEB cells were left untreated (RSV) or primed with 10 ng/ml IL-13 (RSV IL-13) or 10 ng/ml IFN-g (RSV IFN-g) for 24 hours before being exposed to RSV subtype A Memphis 37 at an MOI of 1 for 48 hours. Values were normalized against HPRT and calculated using DCt method; n = 7.
Analysis of Histone Demethylase Function in RIG-I Epigenetic Regulation
As H3K9 methylation appeared to be involved in the IFN-g-mediated epigenetic changes of the RIG-I promoter, we next explored whether the histone-modifying enzymes involved in the regulation of H3K9 tri-and dimethylation were modulated by IFN-g. Unlike monomethylated H3K9, which promotes transcription, di-and trimethylation of H3K9 are capable of preventing activation of gene expression (39) . Several enzymatic complexes are required to modulate methylation, which ultimately regulates transcription and ensures that the epigenetic information is carried over through cellular replication (40) . Based on our finding that IFN-g priming was associated with a reduction of trimethylation of H3K9 at the RIG-I promoter, we investigated two possible options: 1) IFN-g removes methyl residues from H3K9me3 by recruiting demethylases, and 2) IFN-g inhibits the methyltransferases that add methyl groups to H3K9me1 and H3K9me2. To investigate which mechanism is used by IFN-g to modulate RIG-I transcription, we used JIB-04, a pan inhibitor of the activity of the Jumonji family of histone demethylases (41) , and BIX-01294 (a diazepin-quinazolin-amine derivative), which inactivates the lysine methyltransferase G9a that is involved in H3K9me2 methylation (42) . Additionally, to test whether lysinespecific demethylase 1 (LSD1) is involved in mono-and di-demethylation of H3K9, we used pargyline and tranylcypromine as inhibitors (41, 43) Pargyline and tranylcypromine treatment did not cause any significant increase in RIG-I (data not shown), possibly indicating that lysine demethylation of mono-and dimethylation of H3K9 is not involved in IFN-g-mediated RIG-I regulation. After treatment with 1 µM JIB-04, contrary to expectations, we observed a significant increase of RIG-I transcription in IFN-g-primed cells compared with cells treated with JIB-04 alone. The effects of this compound are dose dependent and the concentration we used (1 mM) was aimed at inhibiting JMJD2C (KDM4C), the enzyme responsible for demethylating H3K9me3 ( Figure 7A ). We further analyzed the effects of JIB-04 on the RIG-I promoter by ChIP. Intriguingly, no differences in H3K9me3 were detected at the RIG-I promoter in IFN-g-primed cells after JIB-04 treatment (data not shown). This result suggests that JIB-04 may be acting on RIG-I transcription through other regulatory mechanisms that do not involve H3K9me3. Similarly, no changes were observed for H3K4me3, H3K27me3, H3K9ac, and RNApolII in the presence of JIB-04 (data not shown). The inhibitor JIB-04 without IFN-g priming promoted an increase in transcription, indicating that some of its effects are independent of IFN-g ( Figure 7A ). As the purpose of this investigation was to characterize the regulation mediated by IFN-g, JIB-04 was not investigated any further.
Involvement of Lysine Methyltransferase G9a in RIG-I Epigenetic Regulation
We next studied whether IFN-g modulates RIG-I via inhibition of methylation, possibly interfering with lysine methyltransferase G9a, which uses monomethylated H3K9 (H3K9me1) as a substrate to add a second methyl group (H3K9me2). The activity of G9a leads to an increase of dimethylated H3K9, which then serves as the substrate for H3K9 trimethylation, a transcription-repressive marker. Inhibiting G9a with BIX-01294 should therefore result in an increase of transcription. Treatment of AALEB cells with BIX-01294 alone did not lead to any change in RIG-I expression at either the RNA or protein level. As expected, addition of BIX-01294 to IFN-g-primed cells led to a significant increase in RIG-I expression at both the RNA and protein levels compared with IFN-g alone ( Figures 7B  and 7C ). This suggests the involvement of the lysine methyltransferase G9a in RIG-I epigenetic regulation by IFN-g. ChIP analysis revealed that the levels of H3K9me3 did not change after BIX-01294 treatment alone compared with untreated cells, and with or without IFN-g pretreatment ( Figure E1A ). We observed no correlation between RIG-I expression and the levels of H3K9me2 after BIX-01294 treatment ( Figure E1B ). Taken together, these results suggest that these epigenetic inhibitors may stabilize the IFN-g-induced reduction in H3K9me3, leading to enhanced RIG-I transcription.
To demonstrate that the effects seen on RIG-I were specific, we measured the gene expression levels of a housekeeping gene, glyceraldehyde 3-phosphate dehydrogenase (GAPDH), and found that its expression ( Figure E2A ) and levels of H3K9me3 or me2 ( Figures E2C and E2E) were not affected by IFN-g priming or BIX-01294 treatment. Expression of the Toll-like receptor (TLR) 7 gene was barely detectable by AALEBs, and was not affected by IFN-g priming or BIX-01294 treatment ( Figure E2B ). At the promoter, TLR7 has high levels of the repressive epigenetic marks H3K9me3 and me2 compared with GAPDH consistent with these low transcription levels ( Figures E2D and E2F ). This indicates that the effects of the methyltransferase inhibitor BIX-01294 are gene specific, and here we observed an effect of this inhibitor on IFN-g-regulated genes.
Discussion
We have demonstrated that IFN-g priming of epithelial cells reduces the viral load, and the enhanced RIG-I mRNA expression after IFN-g priming correlated with epigenetic changes at the RIG-I promoter linked with increased transcription. A global gene expression analysis using microarrays after exposing epithelial cells to IFN-g and RSV identified the induction of many epithelial-expressed antiviral genes, including the cytosolic viral sensor RIG-I, which is known for its role in the detection and eradication of replicating viral genomes (28) . RIG-I upregulation was also confirmed by qRT-PCR. IFN-g priming reduced the levels of the transcriptionally repressive histone methylation marker, H3K9me3, at the RIG-I promoter. Furthermore, use of the inhibitors JIB-04 and BIX-01294 suggested that more than one mechanism may be involved in this IFN-g-mediated epigenetic regulation of RIG-I. The specific mechanism of IFN-g priming still needs to be elucidated, but taken together, these results suggest that exposure to IFN-g can prime the antiviral response of the airway epithelium via epigenetic changes in key pathways. Increasingly strong evidence suggests that the environment is capable of inducing innate immune memory and that epigenetic changes, including histone methylation, play an important role in the development and persistence of this memory (44). Ooi and colleagues (45) showed that mechanisms of epigenetic regulation involved in allergic airway inflammation play a key role in the development of a chronic-asthma phenotype. Early life has already been shown to be a critical stage in which allergens, poor air quality, and repeated viral infections can exacerbate preexisting genetic susceptibilities and affect the evolution of asthma (46, 47) . In contrast, exposure to farming environments and endotoxins can lead to higher levels of IFN-g pre-and postnatally, and may be protective against an asthma phenotype (2, (17) (18) (19) . Studies in mice have shown that IFN-g is required for viral clearance (2, 4) , but there are also data showing that IFN-g can prevent replication (27) . Our data do not indicate which of these mechanisms predominate in our model. IL-13 has been linked to airway inflammation and remodeling, but it seems to be a response to RSV rather than the cause of a severe response during viral infection (2, 4) . Our cellular-model data support these conclusions in that the addition of IL-13 did not affect viral load or RIG-I expression, an RNA sensor that is known to have a pivotal role in the antiviral immune response (31) . These data suggest that the "Th2 hypothesis," which holds that an upregulated Th2 and a downregulated Th1 response drive the development of disease (48), may be re-read to indicate that it is a lack of Th1, and not a Th2-predominant immune milieu per se, that drives disease development.
IFN-g regulates downstream genes through the phosphorylation and activation of signal transducer and activator of transcription (STAT)1 homodimers, which activate gamma-activating sequence (GAS) at the promoter of immune-related genes and increase transcription by recruiting IFN regulatory factors (49) . The RIG-I gene is under the regulation of STAT1 (50), and in our model we show that the regulation of RIG-I by IFN-g is further influenced at the epigenetic level by a reduction of the repressive marker H3K9me3 leaving a signature on the histones. Interestingly, Robertson and colleagues (51) showed that 13% of STAT1 promoters do not contain H3K4me3, and similarly we found no involvement of H3K4me3 and H3K27me3 in the regulation of RIG-I transcription. This suggests that the Polycomb/Trithorax enzymatic complex (52) does not modulate RIG-I regulation by IFN-g.
This trimethylation of lysine 9 on histone 3 is associated with heterochromatin and inactive genes, although there are exceptions where methylation on lysine 9 contributes to the regulation of euchromatic genes (53) (54) (55) . In our cellular model, where RIG-I is expressed even in unstimulated cells, the presence of H3K9me3 at low levels is permissive of transcription, and its further reduction after IFN-g priming is linked to an increase of RIG-I gene expression (56) . In an attempt to understand how IFN-g induces these epigenetic changes at the RIG-I promoter, we used small-molecule epigenetic inhibitors. The lysine methyltransferase inhibitor (BIX-01294) and the pan inhibitor of Jumonji histone demethylases (JIB-04) upregulated RIG-I expression in the presence of IFN-g, but neither of them indicated what the epigenetic changes caused by IFN-g priming are. JIB-04 induced a trend toward upregulation of RIG-I expression in AALEB cells in the absence of IFN-g. This observation may suggest a direct correlation between JMJD2C/KDM4C (the enzyme responsible for demethylating H3K9me3), which is inhibited by JIB-04, and RIG-I expression. In the presence of IFN-g, the effect of JIB-04 on RIG-I expression was additive. However, because the primary aim of this investigation was to identify regulatory mechanisms that are mediated purely by IFN-g, we concentrated on BIX-01294, which, in contrast to JIB-04, had significant effects on RIG-I expression only in IFN-g primed cells. BIX-01294 alone did not cause a reduction in the trimethylation levels of H3K9 (H3K9me3) at the RIG-I promoter. Trimethylation of H3K9 was reduced when cells were primed with IFN-g, but was not further reduced in the presence of BIX-01294. This could indicate that these inhibitors may have other, as yet unidentified ways to potentiate the mechanisms used by IFN-g to regulate RIG-I.
Additionally, we investigated whether IFN-g modulates RIG-I by interfering with the lysine methyltransferase G9a (57), which uses monomethylated H3K9 (H3K9me1) as a substrate to add a second methyl group (H3K9me2). The activity of G9a physiologically leads to an increase of H3K9me2a substrate for H3K9me3, which is known to be a transcriptional repressor marker. When we consider that BIX-01294 inhibits G9a involvement in H3K9me2 methylation, we would expect a reduction in the level of H3K9me2 in cells exposed to BIX-01294; however, in our experiments this reduction did not reach significance. The removal of H3K9me2 did not increase RIG-I transcription on its own, and the levels of H3K9me3 remained high, which may have masked any effects produced by BIX-01294. Thus, even though we inhibited demethylases and methyltransferases known to be associated with H3K9 methylation, we saw no effect on baseline methylation. However, IFN-g reduced H3K9me3 of the RIG-I promoter and increased gene transcription in the presence of both inhibitors. Therefore, IFN-g may modulate H3K9 methylation and RIG-I transcription via a different mechanism; further work is required to elucidate this issue. It would also be informative to analyze other areas of the RIG-I promoter to obtain a clearer picture of the histone profile and possibly determine where the effects of the epigenetic inhibitors would be more evident. We may not have investigated the histone markers directly regulated by IFN-g, and what we have shown here may be a downstream effect and not the cause of changes in transcription levels. Our findings do not identify the mechanisms associated with IFN-g regulation, although the results strongly suggest that the cytokine environment may epigenetically modulate genes involved in the viral response and drive innate future responses.
There are limitations to this investigation that may restrict our findings. The use of AALEB cells as an epithelial model instead of primary airway epithelial cells may have given us an incomplete or imperfect picture of the epigenetic profile of the RIG-I promoter. We also did not take into account the effects that other cytokines may have in conjunction with IFN-g on modulating gene expression. Additionally, we analyzed the effects of IFN-g priming after only 24 hours, and although that is sufficient to show an effect on the RIG-I promoter, it is possible that longer time points would have been more informative.
The innate immune response and the Th1/Th2 predisposition in the lung change during the course of life, and these variations are evident in interactions between the host and the environment and correlate with susceptibility to disease (18, 19) . The inflammatory environment of naive epithelial cells may epigenetically modulate innate immune responses, altering the levels of histone methylation and acetylation, and hence may lead to longterm impacts on antiviral immunity. The presence of a Th1 and Th2 milieu appears to play a key role in the development of innate immune responses. The effects of the cytokine milieu on antiviral responses rely on the environmental influences that modulate cytokine production, the genetic background, and the timing of viral infections. Further investigations using ChIP sequencing analysis may identify other genes that are regulated in a similar fashion by cytokines, and clarify mechanisms that once understood may provide a means of modulating the innate Figure 7 . Detection of RIG-I mRNA measured by qRT-PCR in AALEB cells exposed to epigenetic inhibitors. (A) AALEB cells were exposed to 1 mM JIB-04 for 6 hours before IFN-g priming (10 ng/ml) for 24 hours. JIB1IFN-g, JIB-04 exposure and IFN-g priming; IFN-g, IFN-g primed; JIB, exposed to JIB-04 only; UNT, untreated; n = 6. (B) AALEB cells were exposed to 5 mM BIX-01294 for 6 hours before IFN-g priming (10 ng/ml) for 24 hours. BIX1IFN-g, BIX-01294 exposure and IFN-g priming; IFN-g, IFN-g primed; BIX, exposed to BIX-01294 only; UNT, untreated. Both inhibitors upregulated RIG-I expression when cells were also IFN-g primed. Values were normalized against HPRT and calculated using the DCt method; n = 7. (C) Detection of RIG-I protein levels measured by Western blotting after IFN-g priming and BIX-01294 treatment. A representative image from three independent experiments is shown. 40 mg of lysate were added to each lane and tubulin serves as the loading control for each experiment.
system against viral infections and virusinduced asthma.
We have described a potentially important regulatory mechanism that needs to be explored further but may explain the ability of the airway immune environment to modulate gene transcription early in life to prime immune responses. The airway inflammatory milieu, driven by the maturing immune response to the environment, may have important effects on the development of epithelial antiviral innate immunity and the consequent development of its long-term dysregulation, a key feature of asthma. n
